CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,778,376 | -19.2% | 898,400 | -0.1% | 0.66% | -8.8% |
| Q2 2023 | $50,486,702 | +24.1% | 899,300 | -0.1% | 0.72% | +21.8% |
| Q1 2023 | $40,697,954 | +9.8% | 899,800 | -1.3% | 0.59% | +20.1% |
| Q4 2022 | $37,060,808 | -38.9% | 911,705 | -1.8% | 0.49% | -43.5% |
| Q3 2022 | $60,664,000 | +8.3% | 928,305 | +0.7% | 0.87% | +10.0% |
| Q2 2022 | $56,031,000 | -3.7% | 922,005 | -0.5% | 0.79% | +17.2% |
| Q1 2022 | $58,182,000 | -21.2% | 926,905 | -4.9% | 0.68% | -11.2% |
| Q4 2021 | $73,861,000 | -32.3% | 974,684 | 0.0% | 0.76% | -31.3% |
| Q3 2021 | $109,096,000 | -30.3% | 974,684 | +0.8% | 1.11% | -27.6% |
| Q2 2021 | $156,529,000 | +31.3% | 966,884 | -1.2% | 1.53% | +21.2% |
| Q1 2021 | $119,216,000 | -14.4% | 978,384 | +7.6% | 1.26% | -20.9% |
| Q4 2020 | $139,281,000 | +75.4% | 909,684 | -4.2% | 1.60% | +45.4% |
| Q3 2020 | $79,396,000 | +35.0% | 949,262 | +18.6% | 1.10% | +31.7% |
| Q2 2020 | $58,826,000 | +73.3% | 800,462 | 0.0% | 0.83% | +26.6% |
| Q1 2020 | $33,948,000 | -23.7% | 800,462 | +9.6% | 0.66% | -6.7% |
| Q4 2019 | $44,489,000 | +29.6% | 730,462 | -12.7% | 0.70% | +10.5% |
| Q3 2019 | $34,315,000 | -10.1% | 837,162 | +3.3% | 0.64% | -2.1% |
| Q2 2019 | $38,173,000 | – | 810,462 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |